Search

Sullivan, KL, JK Staffetti, RA Hauser, PB Dunne, and TA Zesiewicz. 2006. “Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease.”. Movement Disorders.

Hauser, RA, and T Zesiewicz. 2006. “Clinical Trials Aimed at Detecting Neuroprotection in Parkinson’s Disease.”. Neurology.

Wolfrath, SC, AR Borenstein, S Schwartz, RA Hauser, KL Sullivan, and TA Zesiewicz. 2006. “Use of Nutritional Supplements in Parkinson’s Disease Patients.”. Movement Disorders.

Graff-Radford, J, KD Foote, RL Rodriguez, HH Fernandez, RA Hauser, and . 2006. “Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia. Arch Neurol 2006;63:1181-1184.”. Arch Neurol.

Samanta, J, and RA Hauser. 2006. “Levodopa/Carbidopa/Entacapone for the Treatment of Parkinson’s Disease.”. Aging Health.

Pahwa, R, K Lyons, and RA Hauser. 2004. “Ropinirole Therapy for Parkinson’s Disease. Expert Review of Neurotherapeutics 2004;4:581-588.”. Expert Review of Neurotherapeutics.

Hauser, RA, and K Lyons. 2004. “Future Treatments for Parkinson’s Disease. Neurol Clin 2004;22(Suppl 3):S149-166.”. Neurol Clin.

Zesiewicz, TA, E Encarnacion, and RA Hauser. 2002. “Management of Essential Tremor. Curr Neurol Neurosci Rep 2002;2:324-330.”. Curr Neurol Neurosci Rep.

Group, Parkinson Study. 2002. “A Controlled Trial of Rasagiline in Early Parkinson Disease. Arch Neurol 2002;59:1937-1943.”. Arch Neurol.

Blake, Diane A ", Nurettin Sahiner, Vijay T and John, Antoine D Clinton, Korianne E Galler, Molly Walsh, Analisa Arosemena, Pamela Y Johnson, and Ramesh S Ayyala. 2006. “Inhibition of Cell Proliferation by Mitomycin C Incorporated into P(HEMA) Hydrogels”. J. Glaucoma 15 (4): 291-98.